Prediction of the effects and costs of breast‐cancer screening in Germany

No abstract is available for this paper.

• Publication year

  1994

• Venue

  International Journal of Cancer

• Publication date

  1994-09-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1002/ijc.2910580502PMID 8077045
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness of mammographic screening in Australia.

  2010cited by this paper
• Atlas of Cancer Mortality in the European Economic Community

  1994cited by this paper
• Breast cancer screening with mammography: overview of Swedish randomised trials.

  1993cited by this paper
• National Health Service breast screening programme results for 1991-2.

  1993cited by this paper
• Breast cancer screening with mammography : overview of Swedish randomised trials

  1993cited by this paper
• How cost-effective is breast cancer screening in different EC countries?

  1993cited by this paper
• [Breast cancer: trends from 1964 to 1990. Results of a long-term study].

  1992cited by this paper
• The impact of a breast cancer screening programme on quality‐adjusted life‐years

  1991cited by this paper
• Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors

  1991cited by this paper
• [Surgical and adjuvant therapy of breast cancer].

  1991cited by this paper
• A model for breast cancer screening

  1990cited by this paper
• Die Bedeutung der mammographischen Untersuchung bei der Erkennung von 2511 Mammakarzinomen der Jahre 1977 bis 1986

  1988cited by this paper
• [Significance of mammography study in the detection of 2,511 breast cancers 1977 to 1987].

  1988cited by this paper
• Discounting of Life-Saving and Other Nonmonetary Effects

  1983cited by this paper

• Evaluation der Hautkrebsfrüherkennung in Deutschland – eine Mikrosimulation

  2025cites this paper
• Life Expectancy Predicted by Decision-Analytic Models Evaluating Screening for Prostate, Lung, Breast, and Colorectal Cancer: A Systematic Review Focusing on Competing Mortality Risks

  2025cites this paper
• Evaluation of skin cancer screening in Germany – a Microsimulation

  2024cites this paper
• Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies

  2021cites this paper
• University of Birmingham Valuing the health states associated with breast cancer screening programmes

  2019cites this paper
• Valuing the health states associated with breast cancer screening programmes: A systematic review of economic measures.

  2019cites this paper
• Gesundheitsökonomie der Krebsfrüherkennung in Deutschland: Welche Interventionen sind kosteneffektiv bei bevölkerungsweiter Umsetzung?

  2018cites this paper
• University of Groningen Health technology assessment of imaging technologies for breast cancer screening and follow-up Koleva-Kolarova,

  2017cites this paper
• Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review

  2017cites this paper
• Reply to Koleva-Kolarova et al.

  2016cites this paper
• Simulation models in population breast cancer screening: A systematic review.

  2015cites this paper
• EVALUATION OF THE QUALITY AND USE OF COMPUTER SIMULATION MODELLING IN HEALTH CARE SERVICES

  2014cites this paper
• Breast cancer in European Union: An update of screening programmes as of March 2014 (Review)

  2014cites this paper
• Tactical Versus Operational Discrete Event Simulation: A Breast Screening Case Study

  2014cites this paper
• Cost Effectiveness of Breast Cancer Screening Using Mammography; a Systematic Review

  2013cites this paper
• Cost-effectiveness of opportunistic versus organised mammography screening in Switzerland.

  2009cites this paper
• Cost‐effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40–49 years

  2006cites this paper
• Screening for breast cancer in Catalonia Which policy is to be preferred?

  2005cites this paper
• Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography.

  2005cites this paper
• Gesundheitsökonomische Evaluation des Mammakarzinoms

  2005influential citation
• Systematic review of the use and value of computer simulation modelling in population health and health care delivery

  2004cites this paper
• Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter?

  2004cites this paper
• Descriptive review of the literature on breast cancer outcomes: 1990 through 2000.

  2004cites this paper
• Mammographic screening: evidence from randomised controlled trials.

  2003influential citation
• Systematic review of the use and value of computer simulation modelling in population health and health care delivery.

  2003cites this paper
• [The cost of screening for breast and cervical cancer in France].

  2003cites this paper
• Building a model to determine the cost-effectiveness of breast cancer screening in France.

  2003cites this paper
• EVALUATION OF PREVENTIVE TECHNOLOGIES IN GERMANY

  2001cites this paper
• Breast cancer screening; cost-effective in practice?

  2000influential citation
• Cost-Effectiveness of Population-Based Genetic Hemochromatosis Screening

  2000cites this paper
• Breast cancer screening; cost-effective in practice?

  2000cites this paper
• Investing in early detection versus intensive treatment for breast cancer: a study of the Israeli public priorities

  1999cites this paper
• Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

  1999cites this paper
• Breast cancer screening by mammography in Norway. Is it cost-effective?

  1999cites this paper
• Evaluation of screening programmes: Stud ies on breast cancer and prostate cancer

  1999cites this paper
• Früherkennungsmaßnahmen in der Onkologie

  1998cites this paper
• Economic analyses of radiological procedures: a methodological evaluation of the medical literature.

  1998cites this paper
• Impact of the diagnostic methods on the therapeutic strategies.

  1998cites this paper
• Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study

  1998cites this paper
• Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer

  1998cites this paper
• Radiation risk of mammography related to benefit in screening programmes: a favourable balance?

  1998cites this paper
• Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study

  1998cites this paper
• Anticipating the Consequences for the Primary Therapy of Breast Cancer after Introducing Screening: A More Global Picture for Health Care Policy Making

  1998cites this paper
• Future prospects of population-based mammographic screening.

  1998cites this paper
• Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.

  1997cites this paper
• Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round

  1997cites this paper
• Quantitative estimates of sensitivity and specificity in mammographic screening.

  1997cites this paper
• Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.

  1997cites this paper
• Controversies regarding screening mammography.

  1997cites this paper
• Paracetamol in suicide and non-accidental overdose--are restrictions justified?

  1997cites this paper
• [Breast cancer screening, European Union and France].

  1996cites this paper
• Health education to improve repeat participation in the Dutch breast cancer screening programme: evaluation of a leaflet tailored to previous participants.

  1996cites this paper
• Is mass screening for breast cancer cost-effective?

  1996cites this paper
• 7 Evaluation of screening programmes

  1996cites this paper
• A critical review of screening for breast cancer.

  1996cites this paper
• Adjuvant Therapy of Breast Cancer V

  1996cites this paper
• A critical review of screening for breast cancer.

  1996cites this paper
• Die onkologische Vorsorgeuntersuchung: Nutzen, Kosten, Perspektiven

  1995cites this paper
• Nation‐wide breast cancer screening in the Netherlands: Support for breast‐cancer mortality reduction

  1995cites this paper
• Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.

  1995cites this paper
• Evaluation of mass screening for cancer : a model-based approach

  1995cites this paper
• Changes in use of breast-conserving therapy in years 1978-2000.

  1994cites this paper
• LETTERS TO THE EDITOR Quantitative estimates of sensitivity and specificity in

  year unknowncites this paper
• LETTERS TO THE EDITOR Quantitative estimates of sensitivity and specificity in

  year unknowncites this paper
• LETTERS TO THE EDITOR Quantitative of sensitivity and

  year unknowncites this paper